The current price of BIIB is $243.93 — it has decreased by 4.14% since the previous close. Data as of Nov 5, 2026.
BIIB is down 4.49% over the past week, up 9.10% over the past month and up 58.98% over the past year. The price is above its 200-day moving average of $202.45.
Biogen Inc. has a market capitalization of $36.06B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Companies most comparable to Biogen Inc. include Eli Lilly and Company, AstraZeneca PLC, Amgen Inc., Pfizer Inc. and Vertex Pharmaceuticals Incorporated.
In the latest trading session BIIB moved between $243.65 and $255.70, a range of 4.94% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Biogen Inc. shows a buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks BIIB has traded between $151.83 and $258.78. The current price is 5.74% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.